Business & Finance
Thu, May 6, 2010Mon, January 11, 2010Sun, January 10, 2010Sat, January 9, 2010Fri, January 8, 2010Thu, January 7, 2010Wed, January 6, 2010Tue, January 5, 2010Mon, January 4, 2010Fri, January 1, 2010Thu, December 31, 2009BeBevCo & Koma Unwind Shots Adds Distributor
//business-finance.news-articles.net/content/201 .. /bebevco-koma-unwind-shots-adds-distributor.html
Published in Business and Finance on Wednesday, January 6th 2010 at 7:00 GMT by Market Wire🞛 This publication is a summary or evaluation of another publication
MOORESVILLE, NC--(Marketwire - January 6, 2010) - BeBevCo (
"We have a significant base of Hispanic customers in our locations, and we are very excited about the Potencia Blast Shots with their bilingual labeling, as well as the Koma Unwind shot and its place in the emerging relaxation category," stated Tommy Bagwell.
"The BeBevCo family of products seems to capture the interest of nearly every distributor that we present them to, and Mr. Bagwell, with his previous work with Ten Hour Power, is another exciting partner for us to bring on board," said CEO Brian Weber. "As our network of distributors continues to expand we are very excited about moving this company to the front of the beverage industry, increasing revenue and share value as we go."
BeBevCo (Bebida Beverages Company) develops, manufactures and markets several beverages including: Piranha Water, Guppy Water, Koma Unwind & Koma Unwind Sugar-free Chillaxation Drink ™ and "Koma Chillaxation Shot™" Shot. Potencia Energy Drink and Potencia BLAST energy Shot.
Safe Harbor: This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.